Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Total Intravenous Anesthesia in Percutaneous Transhepatic Cholangiography

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03103672
Recruitment Status : Unknown
Verified March 2017 by Yusuf Ziya ÇOLAK, Inonu University.
Recruitment status was:  Active, not recruiting
First Posted : April 6, 2017
Last Update Posted : April 6, 2017
Sponsor:
Information provided by (Responsible Party):
Yusuf Ziya ÇOLAK, Inonu University

Brief Summary:

Percutaneous transhepatic cholangiography is a disturbing procedure for patients.

TIVA with short-acting anesthetics such as propofol and remifentanil is characterized by hemodynamic stability and better compilation profile The purpose of this study; To compare total intravenous anesthesia with inhalation anesthesia in patients undergoing percutaneous transhepatic cholangiography under general anesthesia.


Condition or disease Intervention/treatment
Percutaneous Transhepatic Cholangiography Procedure: Percutaneous transhepatic cholangiography

Detailed Description:

Percutaneous transhepatic cholangiography is a disturbing procedure for patients. Especially pain at the time of dilation can be a serious problem. These situations may be required local anesthetics, intravenous narcotics and sedatives or general anesthesia (1).

TIVA with short-acting anesthetics such as propofol and remifentanil is characterized by hemodynamic stability and better compilation profile (2).

The purpose of this study; To compare total intravenous anesthesia with inhalation anesthesia in patients undergoing percutaneous transhepatic cholangiography under general anesthesia and Determine their advantages and disadvantages.

  1. Michael J. Lee, Peter R. Mueller, Sanjay Saini, Peter F. Hahn, Stewen L. Dawson. Percutaneous Dilatation of Benign Biliary Strictures: Single-Season Therapy with General Anesthesia. AJR: 157, December 1991: 1263-1266
  2. Xiaoqian Deng, Tao Zhu. Clinical comparison of propofol-remifentanil TCI with sevoflurane induction / maintenance anesthesia in laparoscopic cholecystectomy. Pak J Med Sci 2014 Vol. 30 No. 5: 1017-1021

Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Comparison of Inhalation Anesthesia and Total Intravenous Anesthesia in Percutaneous Transhepatic Cholangiography
Actual Study Start Date : January 2, 2017
Estimated Primary Completion Date : June 1, 2017
Estimated Study Completion Date : July 3, 2017

Group/Cohort Intervention/treatment
Groupe I
Patients who will receive inhalation anesthesia
Procedure: Percutaneous transhepatic cholangiography
Percutaneous transhepatic cholangiography (PTC) can be performed via the right midaxillary approach, though a subxiphoid approach is occasionally needed
Other Name: PTC

Groupe 2
Patients who will receive total intravenous anesthesia
Procedure: Percutaneous transhepatic cholangiography
Percutaneous transhepatic cholangiography (PTC) can be performed via the right midaxillary approach, though a subxiphoid approach is occasionally needed
Other Name: PTC




Primary Outcome Measures :
  1. Recovery time from anesthesia [ Time Frame: up to postoperative 1 hours ]
    Time for Modified Aldrete Score 9 and over


Secondary Outcome Measures :
  1. Heart rate [ Time Frame: up to postoperative 1 hours ]
    Every 5 minutes during the process

  2. Mean blood pressure [ Time Frame: up to postoperative 1 hours ]
    Every 5 minutes during the process



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing percutaneous transhepatic cholangiography
Criteria

Inclusion Criteria:

  • Adult patients undergoing percutaneous transhepatic cholangiography with general anesthesia

Exclusion Criteria:

  • Essential data were missing
  • Patient participating in other research projects
  • Drug allergy
  • Anesthetic complication story

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03103672


Sponsors and Collaborators
Inonu University
Investigators
Layout table for investigator information
Principal Investigator: Yusuf Z Çolak, MD Department of Anesthesia, İnonu Univercity, School of Medicine
Layout table for additonal information
Responsible Party: Yusuf Ziya ÇOLAK, Department of Anesthesiology, Inonu Univercity, School of Medicine, Inonu University
ClinicalTrials.gov Identifier: NCT03103672    
Other Study ID Numbers: 2016/101
First Posted: April 6, 2017    Key Record Dates
Last Update Posted: April 6, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Yusuf Ziya ÇOLAK, Inonu University:
quality of anesthesia
reduce recovery time